BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31342822)

  • 1. Long non-coding RNA NORAD induces cell proliferation and migration in prostate cancer.
    Zhang H; Guo H
    J Int Med Res; 2019 Aug; 47(8):3898-3904. PubMed ID: 31342822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA DUXAP10 promotes the proliferation, migration, and inhibits apoptosis of prostate cancer cells.
    Wang XF; Chen J; Gong YB; Qin YC; Wang L; Li NC
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3699-3708. PubMed ID: 31114994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long noncoding RNA NORAD promotes the growth of gastric cancer cells by sponging miR-608.
    Miao Z; Guo X; Tian L
    Gene; 2019 Mar; 687():116-124. PubMed ID: 30453063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA NORAD upregulate SIP1 expression to promote cell proliferation and invasion in cervical cancer.
    Huo H; Tian J; Wang R; Li Y; Qu C; Wang N
    Biomed Pharmacother; 2018 Oct; 106():1454-1460. PubMed ID: 30119219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer.
    Xu W; Chang J; Du X; Hou J
    Biomed Pharmacother; 2017 Nov; 95():1112-1118. PubMed ID: 28922730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer.
    Li H; Wang X; Wen C; Huo Z; Wang W; Zhan Q; Cheng D; Chen H; Deng X; Peng C; Shen B
    Mol Cancer; 2017 Nov; 16(1):169. PubMed ID: 29121972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA MYU promotes prostate cancer proliferation by mediating the miR-184/c-Myc axis.
    Wang J; Yang X; Li R; Wang L; Gu Y; Zhao Y; Huang KH; Cheng T; Yuan Y; Gao S
    Oncol Rep; 2018 Nov; 40(5):2814-2825. PubMed ID: 30132573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linc00963: a novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence.
    Wang L; Han S; Jin G; Zhou X; Li M; Ying X; Wang L; Wu H; Zhu Q
    Int J Oncol; 2014 Jun; 44(6):2041-9. PubMed ID: 24691949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA CCAT1 promotes the migration and invasion of prostate cancer PC-3 cells.
    Chen H; He Y; Hou YS; Chen DQ; He SL; Cao YF; Wu XM
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2991-2996. PubMed ID: 29863242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NORAD, a critical long non-coding RNA in human cancers.
    Soghli N; Yousefi T; Abolghasemi M; Qujeq D
    Life Sci; 2021 Jan; 264():118665. PubMed ID: 33127516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA AFAP1-AS1 promotes proliferation and invasion in prostate cancer via targeting miR-512-3p.
    Wang K; Sun H; Sun T; Qu H; Xie Q; Lv H; Hu B
    Gene; 2020 Feb; 726():144169. PubMed ID: 31669642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA SAP30L-AS1 promotes prostate cancer growth through repressing SAP30L.
    Qin X; Zhu W; Lu A; Wang G; Ye X; Weng G
    Gene; 2019 Mar; 690():120-128. PubMed ID: 30599235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
    Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
    Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
    Wang J; Cheng G; Li X; Pan Y; Qin C; Yang H; Hua L; Wang Z
    Tumour Biol; 2016 Jul; 37(7):9603-13. PubMed ID: 26797783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA HOTTIP contributes to the progression of prostate cancer by regulating HOXA13.
    Zhang SR; Yang JK; Xie JK; Zhao LC
    Cell Mol Biol (Noisy-le-grand); 2016 Mar; 62(3):84-8. PubMed ID: 27064878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA HOTTIP promotes prostate cancer cells proliferation and migration by sponging
    Yang B; Gao G; Wang Z; Sun D; Wei X; Ma Y; Ding Y
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29884766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel lncRNA
    Lingadahalli S; Jadhao S; Sung YY; Chen M; Hu L; Chen X; Cheung E
    Mol Cancer Res; 2018 Dec; 16(12):1865-1878. PubMed ID: 30115758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.
    Cui Z; Ren S; Lu J; Wang F; Xu W; Sun Y; Wei M; Chen J; Gao X; Xu C; Mao JH; Sun Y
    Urol Oncol; 2013 Oct; 31(7):1117-23. PubMed ID: 22264502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
    Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
    Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.